Related references
Note: Only part of the references are listed.Pomalidomide augments fetal hemoglobin production without the myelosuppressive effects of hydroxyurea in transgenic sickle cell mice
Steffen E. Meiler et al.
BLOOD (2011)
Histone Deacetylase 9 Activates γ-Globin Gene Expression in Primary Erythroid Cells
Shalini A. Muralidhar et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Correction of Sickle Cell Disease in Adult Mice by Interference with Fetal Hemoglobin Silencing
Jian Xu et al.
SCIENCE (2011)
The effect of prolonged administration of hydroxyurea on morbidity and mortality in adult patients with sickle cell syndromes: results of a 17-year, single-center trial (LaSHS)
Ersi Voskaridou et al.
BLOOD (2010)
Transcriptional silencing of γ-globin by BCL11A involves long-range interactions and cooperation with SOX6
Jian Xu et al.
GENES & DEVELOPMENT (2010)
KLF1 regulates BCL11A expression and γ- to β-globin gene switching
Dewang Zhou et al.
NATURE GENETICS (2010)
Chemical genetic strategy identifies histone deacetylase 1 (HDAC1) and HDAC2 as therapeutic targets in sickle cell disease
James E. Bradner et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Histone deacetylase (HDAC) inhibitors in recent clinical trials for cancer therapy
Julia M. Wagner et al.
Clinical Epigenetics (2010)
Inhibition of Histone Deacetylases: A Pharmacological Approach to the Treatment of Non-Cancer Disorders
Norbert L. Wiech et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2009)
Histone Deacetylase Inhibitors Current Status and Overview of Recent Clinical Trials
Xujun Ma et al.
DRUGS (2009)
Pomalidomide and lenalidomide regulate erythropoiesis and fetal hemoglobin production in human CD34(+) cells
Laure A. Moutouh-de Parseval et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Genome-wide association study shows BCL11A associated with persistent fetal hemoglobin and Amelioration of the phenotype of β-thalassemia
Manuela Uda et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
DNA polymorphisms at the BCL11A, HBS1L-MYB, and β-globin loci associate with fetal hemoglobin levels and pain crises in sickle cell disease
Guillaume Lettre et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Human Fetal Hemoglobin Expression Is Regulated by the Developmental Stage-Specific Repressor BCL11A
Vijay G. Sankaran et al.
SCIENCE (2008)
Role of epigenetic modifications in normal globin gene regulation and butyrate-mediated induction of fetal hemoglobin
Hassana Fathallah et al.
BLOOD (2007)
Platelet activation in patients with sickle disease, hemolysis-associated pulmonary hypertension, and nitric oxide scavenging by cell-free hemoglobin
Jose Villagra et al.
BLOOD (2007)
The human Mi-2/NuRD complex and gene regulation
S. A. Denslow et al.
ONCOGENE (2007)
Histone deacetylase inhibitors: molecular mechanisms of action
W. S. Xu et al.
ONCOGENE (2007)
Histone deacetylase inhibitor FK228 is a potent inducer of human fetal haemoglobin
Hua Cao et al.
AMERICAN JOURNAL OF HEMATOLOGY (2006)
Short-chain fatty acids induce γ-globin gene expression by displacement of a HDAC3-NCoR repressor complex
Rishikesh Mankidy et al.
BLOOD (2006)
Functional and morphological recovery of dystrophic muscles in mice treated with deacetylase inhibitors
G. C. Minetti et al.
NATURE MEDICINE (2006)
Fetal hemoglobin induction by histone deacetylase inhibitors involves generation of reactive oxygen species
CH Hsiao et al.
EXPERIMENTAL HEMATOLOGY (2006)
Two catalytic domains are required for protein deacetylation
Y Zhang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Leukocyte adhesion and the pathophysiology of sickle cell disease
H Okpala
CURRENT OPINION IN HEMATOLOGY (2006)
Levels of soluble endothelium-derived adhesion molecules in patients with sickle cell disease are associated with pulmonary hypertension, organ dysfunction, and mortality
GJ Kato et al.
BRITISH JOURNAL OF HAEMATOLOGY (2005)
Phenylbutyrate up-regulates the adrenoleukodystrophy-related gene as a nonclassical peroxisome proliferator
C Gondcaille et al.
JOURNAL OF CELL BIOLOGY (2005)
Activation and signaling of the p38 MAP kinase pathway
T Zarubin et al.
CELL RESEARCH (2005)
Molecular evolution of the histone deacetylase family: Functional implications of phylogenetic analysis
IV Gregoretti et al.
JOURNAL OF MOLECULAR BIOLOGY (2004)
Induction of human γ globin gene expression by histone deacetylase inhibitors
H Cao et al.
BLOOD (2004)
Class II histone deacetylases: versatile regulators
E Verdin et al.
TRENDS IN GENETICS (2003)
Effect of hydroxyurea on mortality. and morbidity in adult sickle cell anemia - Risks and benefits up to 9 years of treatment
MH Steinberg et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
HbF reactivation in sibling BFU-E colonies: synergistic interaction of kit ligand with low-dose dexamethasone
M Gabbianelli et al.
BLOOD (2003)
Histone deacetylases (HDACs): characterization of the classical HDAC family
AJM De Ruijter et al.
BIOCHEMICAL JOURNAL (2003)
Effects of 5-aza-2 '-deoxycytidine on fetal hemoglobin levels, red cell adhesion, and hematopoietic differentiation in patients with sickle cell disease
Y Saunthararajah et al.
BLOOD (2003)
Maintenance of elevated fetal hemoglobin levels by decitabine during dose interval treatment of sickle cell anemia
J DeSimone et al.
BLOOD (2002)
Histone-deacetylase inhibitors: Novel drugs for the treatment of cancer
RW Johnstone
NATURE REVIEWS DRUG DISCOVERY (2002)
Developmentally dynamic histone acetylation pattern of a tissue-specific chromatin domain
EC Forsberg et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Share Paper
